You are not logged in.
This means
you CAN ONLY VIEW reports that were published prior to Monday, October 21, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
 MIDDAY BREAKOUTS REPORT - TUESDAY, MARCH 31ST, 2020
Previous Mid Day Report Next Mid Day Report >>>
|
|
DOW 22399.99 72.51 (0.32%) | NASDAQ 7816.6 42.45 (0.55%) | S&P 500 2637.04 10.39 (0.40%)
|
Time of Screening :
3/31/2020 12:08:30 PM Report Released :
3/31/2020 12:29:08 PM
Price is:
Above 52W High and Less Than 52W High
but within 15% of the 52 Week High
Volume Is:
At least 50% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
|
NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.
|
|
 |
Symbol - Exchange - Industry Group
Company Name |
Last |
Chg |
Day
High |
52 WK Hi |
% From Hi |
Volume
% DAV |
DAV |
ABT
- NYSE - DRUGS - Drug Manufacturers - Major
Abbott Laboratories
|
$80.47 |
+1.13
1.42%
|
$81.49
|
$92.45
|
-12.96% |
12,475,208
138.91%
|
8,981,000
|
Most Recent Note for ABT - 3/31/2020 12:09:57 PM
Rebounded to challenge its 200 DMA line ($84) with a gap up and big volume-driven gain on the prior session following approval of a rapid coronavirus test. Reported earnings +17% on +7% sales revenues for the Dec '19 quarter versus the year ago period. Prior quarterly comparisons versus the year ago periods were below the +25% minimum guideline (C criteria).
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AUDC
- NASDAQ - ELECTRONICS - Scientific & Technical Instrum
Audiocodes Ltd
|
$25.01 |
+1.50
6.38%
|
$25.79
|
$28.73
|
-12.95% |
268,735
55.07%
|
488,000
|
Most Recent Note for AUDC - 3/31/2020 12:11:49 PM
Rebounding impressively after a deep pullback since dropped from the Featured Stocks list when last noted on 2/27/20. Faces some resistance due to overhead supply up to the $28 level. Fundamentals remain strong after it reported earnings +30% on +15% sales revenues for the Dec '19 quarter.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DG
- NYSE - RETAIL - Discount, Variety Stores
Dollar General Corp
|
$153.54 |
+6.77
4.61%
|
$154.30
|
$167.44
|
-8.30% |
1,485,338
61.53%
|
2,414,000
|
Most Recent Note for DG - 3/31/2020 12:13:07 PM
Rebounding above its 200 DMA line ($152) and challenging its 50 DMA line ($154) after an abrupt slump from its all-time high. Reported earnings +12% on +8% sales revenues for the Jan '20 quarter and prior quarters were below the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth history has been steady.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DGICA
- NASDAQ - Insurance-Prop/Cas/Titl
Donegal Group Inc Cl A
|
$14.68 |
-0.18
-1.18%
|
$14.90
|
$15.43
|
-4.89% |
27,112
93.49%
|
29,000
|
Most Recent Note for DGICA - 3/31/2020 12:13:39 PM
Prior quarterly sales revenues and earnings growth has not been strong and steady. Annual earnings (A criteria) history also has been up and down.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DOCU
- NASDAQ - Computer Sftwr-Enterprse
Docusign Inc
|
$94.37 |
+6.23
7.07%
|
$98.38
|
$92.55
|
1.97% |
3,165,749
116.95%
|
2,707,000
|
Most Recent Note for DOCU - 3/31/2020 12:20:10 PM
Hit a new all-time high with today's 2nd consecutive big volume-driven gain. It did not form a sound base yet rallied impressively after recently finding support at its 200 DMA line ($66). Earnings history included a -67% comparison in the Jul '19 quarter versus the year ago period, but otherwise results have been very strong with solid sales revenues growth.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DPZ
- NYSE - Retail-Restaurants
Dominos Pizza Inc
|
$327.00 |
-19.76
-5.70%
|
$330.84
|
$381.86
|
-14.37% |
801,474
76.19%
|
1,052,000
|
Most Recent Note for DPZ - 3/31/2020 12:21:30 PM
Gapped down today. Pulled back and tested support at its 200 DMA line since stalling after a 2/20/20 gap up for a new all-time high. Reported earnings +19% on +6% sales revenues for the Dec '19 quarter, its 4th consecutive quarterly comparison below the +25% minimum guideline (C criteria). Annual earnings history has been strong and steady, satisfying the A criteria. Went through a choppy consolidation since dropped from the Featured Stocks list on 11/19/18.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVDA
- NASDAQ - ELECTRONICS - Semiconductor - Specialized
Nvidia Corp
|
$269.60 |
+4.01
1.51%
|
$275.40
|
$316.32
|
-14.77% |
9,017,149
60.70%
|
14,856,000
|
Most Recent Note for NVDA - 3/31/2020 12:24:44 PM
Rebounded above its 50 DMA line ($254) after an abrupt retreat recently tested its 200 DMA line ($206). Reported earnings +136% on +41% sales revenues for the Jan '20 quarter versus the year ago period. The 4 prior quarterly comparisons had lower sales revenues and lower earnings (negative comparisons) versus the year ago periods. Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
QDEL
- NASDAQ - DRUGS - Diagnostic Substances
Quidel Corp
|
$96.46 |
-7.18
-6.93%
|
$106.56
|
$105.63
|
-8.68% |
330,904
73.70%
|
449,000
|
Most Recent Note for QDEL - 3/31/2020 12:26:47 PM
This San Diego, CA based maker of rapid diagnostic tests for infectious diseases reversed into the red today after spiking to a new all-time high with 3 consecutive volume-driven gains. It has earned a high Earnings Per Share rating of 95. Reported earnings +23% on +15% sales revenues for the Dec '19 quarter and prior quarterly earnings comparisons were below the +25% minimum guideline (C criteria). Annual earnings (A criteria) history include a slight downturn in FY '19 following strong earnings growth in FY '17 and '18.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ZM
- NASDAQ - Computer Sftwr-Enterprse
Zoom Video Comm Cl A
|
$145.57 |
-5.31
-3.52%
|
$149.79
|
$164.94
|
-11.74% |
5,732,062
58.97%
|
9,720,000
|
Most Recent Note for ZM - 3/31/2020 12:27:24 PM
Perched near its all-time high after a noted spurt of volume-driven gains, and it is very extended from any sound base. Completed its $36.00 IPO on 4/18/19. Limited annual history (A criteria) is a concern. Reported earnings +275% on +78% sales revenues for the Jan '20 quarter. Prior quarterly comparisons also showed very strong sales revenues and great earnings increases versus the year ago periods.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ZTO
- NYSE - Transportation-Logistics
ZTO Express (Cayman) Inc
|
$26.46 |
+0.68
2.64%
|
$26.50
|
$28.06
|
-5.70% |
1,498,666
54.74%
|
2,738,000
|
Most Recent Note for ZTO - 3/31/2020 12:29:00 PM
Perched within striking distance of its all-time high. Found prompt support near its 50 DMA line ($24.43). Reported earnings +79% on +20% sales revenues for the Dec '19 quarter, its 2nd strong quarterly earnings comparison. Prior quarterly earnings increases have been below the +25% minimum guideline (C criteria). History is limited since its $19.50 IPO in October 2016.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|
